| Company Name: |
Wuhan BJM Pharm Inc Gold |
| Tel: |
18607102166 18607102166 |
| Email: |
sales04@benjaminpharmchem.com |
- levomenol
-
- $3.00
-
2026-08-25
- CAS:23089-26-1
- Purity: 99%
- (-)-α-Bisabolol
-
-
2026-08-08
- CAS:23089-26-1
- Min. Order: 1kg
- Purity: 99.0%
- Supply Ability: 20 tons
- Levomenol
-
- $77.00
-
2026-06-02
- CAS:23089-26-1
- Purity: 99.43%
- Supply Ability: 10g
|
| | (-)-alpha-bisabolol Basic information | | Synthesis |
| | (-)-alpha-bisabolol Chemical Properties |
| alpha | D -55.7°; D20 -51.02° (Günther) | | Boiling point | bp12 153° | | density | d20 0.9211 | | vapor pressure | 0.015Pa at 20℃ | | refractive index | n20/D 1.496 | | FEMA | 4666 | ALPHA-BISABOLOL | | Fp | 135 °C | | storage temp. | -20°C | | solubility | DMSO:100.0(Max Conc. mg/mL);449.7(Max Conc. mM) | | form | Liquid | | pka | 15.04±0.29(Predicted) | | color | Colorless to light yellow | | Odor | at 100.00 %. fruity nutty coconut | | Odor Type | floral | | Optical Rotation | [α]/D -60±2°, neat | | Water Solubility | 22mg/L at 20℃ | | JECFA Number | 2031 | | Cosmetics Ingredients Functions | SKIN CONDITIONING
SOOTHING
FRAGRANCE | | InChI | 1S/C15H26O/c1-12(2)6-5-11-15(4,16)14-9-7-13(3)8-10-14/h6-7,14,16H,5,8-11H2,1-4H3/t14-,15+/m1/s1 | | InChIKey | RGZSQWQPBWRIAQ-CABCVRRESA-N | | SMILES | O[C@]([C@H]1CCC(=CC1)C)(CCC=C(C)C)C | | LogP | 5.5 at 25℃ | | CAS DataBase Reference | 23089-26-1(CAS DataBase Reference) | | EPA Substance Registry System | Levomenol (23089-26-1) |
| RIDADR | UN 3082 9 / PGIII | | WGK Germany | 3 | | RTECS | MJ9685000 | | HS Code | 2906195000 | | Storage Class | 10 - Combustible liquids | | Hazard Classifications | Aquatic Chronic 3 | | Toxicity | LD50 in male, female mice, rats (ml/kg): 15.2, 15.0, 14.9, 15.6 orally (Habersang) |
| | (-)-alpha-bisabolol Usage And Synthesis |
| Synthesis | (a) Chemical Synthesis: Racemic bisabolol is prepared by chemical synthesis using farnesol (farnesol) or nerol as starting materials. The synthesized product obtained from this process is a racemic product with a content of 85%, containing two isomers: 42.5% levorotatory (-)α-bisabolol and 42.5% dextrorotatory (+)α-bisabolol. This mixture contains only 42.5% of the active levorotatory isomer. 
(II) Plant Extraction Method: Using raw materials such as chamomile and Candeia brasiliensis, natural α-bisabolol is fractionated from essential oils: the fractionation process separates components from a liquid mixture based on their boiling points, and a single configuration of bisabolol is prepared through extractive distillation. (III) Biosynthesis Method: Using corn as raw material, (-)-alpha-bisabolol is obtained through biosynthesis technology. | | Description | Bisabolol, or more formally (-)-alpha-bisabolol, also known as levomenol, is a natural monocyclic sesquiterpene alcohol. Alpha-bisabolol, an unsaturated monocyclic sesquiterpene alcohol, is known as one of the “most-used herbal constituents” worldwide. Various therapeutic and biological properties of α-bisabolol in preventing oxidative stress, inflammatory disorders, infections, neurodegenerative diseases, cancers, and metabolic disorders have been reported. It is a common additive in many PCPs, including dental care products, skin moisturisers, sunscreens, and make-up products, due to its multiple biological activities.
| | Uses | (-)-α-Bisabolol was used to investigate the leishmanicidal and cytotoxic activity of essential oil of Vanillosmopsis arborea. | | Uses | Reference Standard in the analysis of herbal medicinal products | | Definition | ChEBI: (-)-alpha-Bisabolol is a sesquiterpenoid. | | benefits | The benefits of Bisabolol (or α-bisabolol) on the skin include soothing, anti-aging, maintaining skin firmness, improving skin pigmentation and moisturising the skin to reduce the appearance of fine lines. | | General Description | (-)-α-Bisabolol is the major constituent of essential oil from leaves of Hymenocrater yazdianus. | | Flammability and Explosibility | Not classified | | Biochem/physiol Actions | α-Bisabolol is active against primary acute leukemia cells, including BCR-ABL(+) acute lymphoblastic leukemias. It is the inhibitor of voltage-dependent Ca(2+) channels in tracheal smooth muscle preparations of rat. It also inhibits human and rat glioma cell growth and survival. It is a potential new therapeutic agent against leishmaniasis. |
| | (-)-alpha-bisabolol Preparation Products And Raw materials |
|